MARKET

RECEF

RECEF

Recce Pharmaceut
OTCPK
0.500
NaN%
Closed 09:30 05/16 EDT
OPEN
--
PREV CLOSE
0.500
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.600
52 WEEK LOW
0.500
MARKET CAP
144.19M
P/E (TTM)
-8.8028
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RECEF last week (0505-0509)?
Weekly Report · 5d ago
Weekly Report: what happened at RECEF last week (0428-0502)?
Weekly Report · 05/05 10:53
Weekly Report: what happened at RECEF last week (0421-0425)?
Weekly Report · 04/28 11:00
Weekly Report: what happened at RECEF last week (0414-0418)?
Weekly Report · 04/21 11:00
Weekly Report: what happened at RECEF last week (0407-0411)?
Weekly Report · 04/14 10:51
Weekly Report: what happened at RECEF last week (0331-0404)?
Weekly Report · 04/07 10:51
Weekly Report: what happened at RECEF last week (0324-0328)?
Weekly Report · 03/31 11:00
Weekly Report: what happened at RECEF last week (0317-0321)?
Weekly Report · 03/24 10:50
More
About RECEF
Recce Pharmaceuticals Ltd is an Australia-based company engaged in the development and commercialization of a new class of synthetic anti-infectives designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral pathogens. The Company's anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company's anti-infectives have the potential to overcome the hypercellular mutation of bacteria and viruses. All RECCE compounds are water soluble at all pH levels in their liquid form.

Webull offers Recce Pharmaceuticals Ltd stock information, including OTCPK: RECEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RECEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RECEF stock methods without spending real money on the virtual paper trading platform.